Doctors are looking at new ways to treat acromegaly, a condition where the body produces too much growth hormone. In some regions, like the Gulf, patients often have advanced disease and complex health issues. Standard treatments have shown lower success rates in these areas compared to other parts of the world.
The new guidelines suggest a biomarker-guided approach. This means doctors use specific MRI signals and tumor granulation patterns to choose the best medicine for each patient. This method aims to improve biochemical control, which is a key goal in managing the condition.
While the guidelines suggest this approach could help patients get better results, it is important to note that the evidence is based on regional guidelines rather than a large clinical trial. The goal is to tailor treatment to the specific needs of patients with advanced disease. Patients should talk to their doctors about how these new guidelines might apply to their specific treatment plan.
